{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:10:46Z","timestamp":1794035446178,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with an extremely low survival rate. New and effective approaches for treatment are therefore urgently needed. Here, we successfully developed M1-like macrophage-derived extracellular vesicles (M1EVs) that overcome multiple challenges via guidance from two macrophage-related observations in clinical specimens from GBM patients: enrichment of M2 macrophages in GBM; and origination of a majority of infiltrating macrophage from peripheral blood. To maximize the synergistic effect, we further functionalized the membranes of M1EVs with two hydrophobic agents (the chemical excitation source CPPO (C) and the photosensitizer Ce6 (C)) and loaded the hydrophilic hypoxia-activated prodrug AQ4N (A) into the inner core of the M1EVs. After intravenous injection, the inherent nature of M1-derived extracellular vesicles CCA-M1EVs allowed for blood-brain barrier penetration, and modulated the immunosuppressive tumor microenvironment via M2-to-M1 polarization, which increased hydrogen peroxide (H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    ) levels. Furthermore, the reaction between H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    and CPPO produced chemical energy, which could be used for Ce6 activation to generate large amounts of reactive oxygen species to achieve chemiexcited photodynamic therapy (CDT). As this reaction consumed oxygen, the aggravation of tumor hypoxia also led to the conversion of non-toxic AQ4N into toxic AQ4 for chemotherapy. Therefore, CCA-M1EVs achieved synergistic immunomodulation, CDT, and hypoxia-activated chemotherapy in GBM to exert a potent therapeutic effect. Finally, we demonstrated the excellent effect of CCA-M1EVs against GBM in cell-derived xenograft and patient-derived xenograft models, underscoring the strong potential of our highly flexible M1EVs system to support multi-modal therapies for difficult-to-treat GBM.\n                  <\/jats:p>","DOI":"10.1038\/s41392-022-00894-3","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:02:28Z","timestamp":1647378148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects"],"prefix":"10.1038","volume":"7","author":[{"given":"Xiaojun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaonan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-5556","authenticated-orcid":false,"given":"Guanghui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-3187","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"894_CR1","doi-asserted-by":"publisher","first-page":"e2000416","DOI":"10.1002\/adma.202000416","volume":"32","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment. Adv. Mater. 32, e2000416 (2020).","journal-title":"Adv. Mater."},{"key":"894_CR2","doi-asserted-by":"publisher","first-page":"e1903759","DOI":"10.1002\/adma.201903759","volume":"32","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors. Adv. Mater. 32, e1903759 (2020).","journal-title":"Adv. Mater."},{"key":"894_CR3","doi-asserted-by":"publisher","first-page":"e1903277","DOI":"10.1002\/adma.201903277","volume":"31","author":"M Zheng","year":"2019","unstructured":"Zheng, M. et al. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy. Adv. Mater. 31, e1903277 (2019).","journal-title":"Adv. Mater."},{"key":"894_CR4","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1002\/anie.202007474","volume":"59","author":"C Qiao","year":"2020","unstructured":"Qiao, C. et al. Rabies Virus-Inspired Metal-Organic Frameworks (MOFs) for Targeted Imaging and Chemotherapy of Glioma. Angew. Chem. 59, 16982\u201316988 (2020).","journal-title":"Angew. Chem."},{"key":"894_CR5","doi-asserted-by":"crossref","unstructured":"Polson, E. S. et al. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice. Sci. Transl. Med. 10, eaar2718 (2018).","DOI":"10.1126\/scitranslmed.aar2718"},{"key":"894_CR6","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu, H. et al. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. Cell 175, 1665\u20131678 e1618 (2018).","journal-title":"Cell"},{"key":"894_CR7","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1001\/jamaoncol.2020.4937","volume":"6","author":"N Lamba","year":"2020","unstructured":"Lamba, N. et al. Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma. JAMA Oncol. 6, 1972\u20131974 (2020).","journal-title":"JAMA Oncol."},{"key":"894_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41578-019-0135-y","volume":"4","author":"KJ Wolf","year":"2019","unstructured":"Wolf, K. J., Chen, J., Coombes, J., Aghi, M. K. & Kumar, S. Dissecting and rebuilding the glioblastoma microenvironment with engineered materials. Nat. Rev. Mater. 4, 651\u2013668 (2019).","journal-title":"Nat. Rev. Mater."},{"key":"894_CR9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1039\/C7CS00471K","volume":"47","author":"H Lin","year":"2018","unstructured":"Lin, H., Chen, Y. & Shi, J. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy. Chem. Soc. Rev. 47, 1938\u20131958 (2018).","journal-title":"Chem. Soc. Rev."},{"key":"894_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nbt.4071","volume":"36","author":"S Li","year":"2018","unstructured":"Li, S. et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat. Biotechnol. 36, 258\u2013264 (2018).","journal-title":"Nat. Biotechnol."},{"key":"894_CR11","doi-asserted-by":"publisher","first-page":"0011","DOI":"10.1038\/s41551-016-0011","volume":"1","author":"W Chao","year":"2017","unstructured":"Chao, W. et al. In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy. Nat. Biomed. Eng. 1, 0011 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"894_CR12","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang, W. et al. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem. Soc. Rev. 48, 2967\u20133014 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"894_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks, W. A. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov. 15, 275\u2013292 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"894_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nnano.2017.54","volume":"12","author":"J Xue","year":"2017","unstructured":"Xue, J. et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 12, 692\u2013700 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"894_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrmicro.2016.178","volume":"15","author":"M Coureuil","year":"2017","unstructured":"Coureuil, M., Lecuyer, H., Bourdoulous, S. & Nassif, X. A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat. Rev. Microbiol. 15, 149\u2013159 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"894_CR16","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.1021\/acsnano.0c02509","volume":"14","author":"D Reichel","year":"2020","unstructured":"Reichel, D. et al. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma. ACS Nano 14, 8392\u20138408 (2020).","journal-title":"ACS Nano"},{"key":"894_CR17","doi-asserted-by":"publisher","first-page":"1909369","DOI":"10.1002\/adfm.201909369","volume":"30","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood\u2013Brain Barrier for Imaging and Therapy of Brain Tumors. Adv. Funct. Mater. 30, 1909369 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"894_CR18","doi-asserted-by":"publisher","first-page":"e1802591","DOI":"10.1002\/adma.201802591","volume":"30","author":"B Guo","year":"2018","unstructured":"Guo, B. et al. Through Scalp and Skull NIR-II Photothermal Therapy of Deep Orthotopic Brain Tumors with Precise Photoacoustic Imaging Guidance. Adv. Mater. 30, e1802591 (2018).","journal-title":"Adv. Mater."},{"key":"894_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar, V. et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer cell 32, 654\u2013668 e655 (2017).","journal-title":"Cancer cell"},{"key":"894_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrc3581","volume":"13","author":"JE Talmadge","year":"2013","unstructured":"Talmadge, J. E. & Gabrilovich, D. I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 13, 739\u2013752 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"894_CR21","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Thery, C. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"894_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrn.2015.29","volume":"17","author":"V Budnik","year":"2016","unstructured":"Budnik, V., Ruiz-Canada, C. & Wendler, F. Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 17, 160\u2013172 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"894_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015).","journal-title":"Nature"},{"key":"894_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"ELA S","year":"2013","unstructured":"S, E. L. A., Mager, I., Breakefield, X. O. & Wood, M. J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347\u2013357 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"894_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012).","journal-title":"Nat. Med."},{"key":"894_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341\u2013345 (2011).","journal-title":"Nat. Biotechnol."},{"key":"894_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569\u2013579 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"894_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nnano.2010.148","volume":"5","author":"JB Haun","year":"2010","unstructured":"Haun, J. B., Devaraj, N. K., Hilderbrand, S. A., Lee, H. & Weissleder, R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat. Nanotechnol. 5, 660\u2013665 (2010).","journal-title":"Nat. Nanotechnol."},{"key":"894_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat. Biomed. Eng. 4, 69\u201383 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"894_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.07.001","volume":"262","author":"D Rufino-Ramos","year":"2017","unstructured":"Rufino-Ramos, D. et al. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. J. Control. Release 262, 247\u2013258 (2017).","journal-title":"J. Control. Release"},{"key":"894_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","volume":"192","author":"L Pascucci","year":"2014","unstructured":"Pascucci, L. et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery. J. Control. Release 192, 262\u2013270 (2014).","journal-title":"J. Control. Release"},{"key":"894_CR32","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ncomms2282","volume":"3","author":"K Tang","year":"2012","unstructured":"Tang, K. et al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat. Comm. 3, 1282 (2012).","journal-title":"Nat. Comm."},{"key":"894_CR33","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1038\/s41467-018-07197-8","volume":"9","author":"Z Yu","year":"2018","unstructured":"Yu, Z., Zhou, P., Pan, W., Li, N. & Tang, B. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis. Nat. Comm. 9, 5044 (2018).","journal-title":"Nat. Comm."},{"key":"894_CR34","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm, F. et al. Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells. Cell 181, 1643\u20131660 e1617 (2020).","journal-title":"Cell"},{"key":"894_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/2159-8290.CD-19-0400","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen, P. et al. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Disco. 10, 371\u2013381 (2020).","journal-title":"Cancer Disco."},{"key":"894_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy, T. F. et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat. Med. 25, 477\u2013486 (2019).","journal-title":"Nat. Med."},{"key":"894_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1362-4","volume":"18","author":"S Muller","year":"2017","unstructured":"Muller, S. et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol. 18, 234 (2017).","journal-title":"Genome Biol."},{"key":"894_CR38","doi-asserted-by":"publisher","first-page":"eaat7828","DOI":"10.1126\/sciadv.aat7828","volume":"4","author":"CE Gast","year":"2018","unstructured":"Gast, C. E. et al. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci. Adv. 4, eaat7828 (2018).","journal-title":"Sci. Adv."},{"key":"894_CR39","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425\u20136440 (2018).","journal-title":"J. Cell. Physiol."},{"key":"894_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445\u2013455 (2013).","journal-title":"Nature"},{"key":"894_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 4, 309\u2013324 (2009).","journal-title":"Nat. Protoc."},{"key":"894_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4, 359\u2013365 (2007).","journal-title":"Nat. Methods"},{"key":"894_CR43","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1039\/C7PY00559H","volume":"8","author":"G Lazzari","year":"2017","unstructured":"Lazzari, G., Couvreur, P. & Mura, S. Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines. Polym. Chem. 8, 4947\u20134969 (2017).","journal-title":"Polym. Chem."},{"key":"894_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1158\/2159-8290.CD-20-0493","volume":"10","author":"X Luo","year":"2020","unstructured":"Luo, X. & Weiss, W. A. Utility of Human-Derived Models for Glioblastoma. Cancer Disco. 10, 907\u2013909 (2020).","journal-title":"Cancer Disco."},{"key":"894_CR45","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","volume":"15","author":"F Jacob","year":"2020","unstructured":"Jacob, F., Ming, G. L. & Song, H. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nat. Protoc. 15, 4000\u20134033 (2020).","journal-title":"Nat. Protoc."},{"key":"894_CR46","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1038\/s41467-018-07334-3","volume":"9","author":"EC Randall","year":"2018","unstructured":"Randall, E. C. et al. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat. Comm. 9, 4904 (2018).","journal-title":"Nat. Comm."},{"key":"894_CR47","doi-asserted-by":"crossref","unstructured":"Jafari, D., Malih, S., Eini, M., Jafari, R. & Samadikuchaksaraei, A. Improvement, scaling-up, and downstream analysis of exosome production. Crit. Rev. Biotechno. 40, 1098\u20131112 (2020).","DOI":"10.1080\/07388551.2020.1805406"},{"key":"894_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang, Z., Shi, J., Xie, J., Wang, Y. & Lee, L. J. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat. Biomed. Eng. 4, 1\u201315 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"894_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature23000","volume":"547","author":"TE Miller","year":"2017","unstructured":"Miller, T. E. et al. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature 547, 355\u2013359 (2017).","journal-title":"Nature"},{"key":"894_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. Cell 180, 188\u2013204 e122 (2020).","journal-title":"Cell"},{"key":"894_CR51","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"894_CR52","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.7717\/peerj-cs.67","volume":"2","author":"J Anaya","year":"2016","unstructured":"Anaya, J. OncoLnc: Linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput. Sci. 2, e67 (2016).","journal-title":"PeerJ Comput. Sci."},{"key":"894_CR53","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244\u20131247 (2008).","journal-title":"Science"},{"key":"894_CR54","first-page":"Unit 3 22","volume":"Chapter 3","author":"C Thery","year":"2006","unstructured":"Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 22 (2006).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"894_CR55","doi-asserted-by":"publisher","first-page":"e1804693","DOI":"10.1002\/adma.201804693","volume":"30","author":"J Zhuang","year":"2018","unstructured":"Zhuang, J. et al. Biomimetic Nanoemulsions for Oxygen Delivery In Vivo. Adv. Mater. 30, e1804693 (2018).","journal-title":"Adv. Mater."},{"key":"894_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41556-018-0039-x","volume":"20","author":"A Hervera","year":"2018","unstructured":"Hervera, A. et al. Reactive oxygen species regulate axonal regeneration through the release of exosomal NADPH oxidase 2 complexes into injured axons. Nat. Cell Biol. 20, 307\u2013319 (2018).","journal-title":"Nat. Cell Biol."}],"updated-by":[{"DOI":"10.1038\/s41392-026-02976-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000}}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00894-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:02:11Z","timestamp":1788642131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-00894-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-00894-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41392-026-02976-y","URL":"https:\/\/doi.org\/10.1038\/s41392-026-02976-y","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"74"}}